Yongmei Yin

Pyrotinib plus capecitabine for human epidermal growth factor receptor 2-positive metastatic breast cancer after trastuzumab and taxanes (PHENIX): a randomized, double-blind, placebo-controlled phase 3 study

Min Yan, Li Bian, Xichun Hu et al. · Translational Breast Cancer Research · 2020 · 107 citations · Full text

Medicine, Oncology, Pharmacology +17

Chinese society of clinical oncology (CSCO) Breast Cancer Guidelines 2022

Zefei Jiang, Erwei Song, Cuizhi Geng et al. · Translational Breast Cancer Research · 2022 · 71 citations · Full text

Medicine, Oncology, Breast Oncology +15

CACA Guidelines for Holistic Integrative Management of Breast Cancer

Jiong Wu, Daiming Fan, Zhimin Shao et al. · Holistic Integrative Oncology · 2022 · 61 citations · Full text

Medicine, Oncology, Breast Oncology +10

MiR-4319 Suppress the Malignancy of Triple-Negative Breast Cancer by Regulating Self-Renewal and Tumorigenesis of Stem Cells

Jiahui Chu, Yongfei Li, Xuemei Fan et al. · Cellular Physiology and Biochemistry · 2018 · 49 citations · Full text

Medicine, Cancer Biology, Oncology +17

Effect of an Artificial Intelligence Clinical Decision Support System on Treatment Decisions for Complex Breast Cancer

Fengrui Xu, Martin Sepulveda, Zefei Jiang et al. · JCO Clinical Cancer Informatics · 2020 · 46 citations · Full text

Computing, Biomedical Informatics, Oncology +16